Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29022080 | 0.89 | CDC25A (0.34) | BBOX1SMN1; SMN2 | |
| SCHEMBL12735215 | 0.85 | APP (0.32) | — | |
| SCHEMBL11010044 | 0.84 | CDC25A (0.39) | BBOX1SMN1; SMN2TSHRMAPK1 | |
| Sulfuric Acid SCHEMBL21819838 | 0.83 | CDC25A (0.40) | TSHRMAPK1 | |
| SCHEMBL738651 | 0.83 | SMN1; SMN2 (0.46) | BBOX1SMN1; SMN2GMNNALDH1A1LMNA | |
| SCHEMBL18526268 | 0.82 | CTDSP1 (0.33) | — | |
| SCHEMBL27191541 | 0.79 | APP (0.33) | — | |
| SCHEMBL15819766 | 0.79 | HPGD (0.41) | BBOX1SMN1; SMN2GMNNALDH1A1LMNA | |
| SCHEMBL9936322 | 0.78 | HPGD (0.34) | — | |
| Sulfuric Acid SCHEMBL21819840 | 0.77 | CDC25A (0.38) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2430195-B1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA INC (US) | 2019-01-23 | — | — | EP | disclosed |
| US-20140065627-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| US-8519125-B2 | Compositions and methods for biological sample storage | BIOMATRICA, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| EP-2430195-A2 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | Biomatrica, INC. (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20110081363-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2011-04-07 | — | — | US | disclosed |
| WO-2010132508-A2 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110081363-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | DNASE1, DIS3, NEFM | BBOX1 1347/4885SMN1; SMN2 351/4885GMNN 2039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.